Syneos Health

Syneos Health Book Value per Share

Delisted

The Book Value per Share of Syneos Health (SYNH) as of Oct 30, 2026 is 33.78 USD. In the previous year, Book Value per Share was 32.98 USD — a change of 2.42% (higher).

Book Value per Share

33.78USD

YoY

2.42%

Last updated:

Book Value per Share of Syneos Health is 2022 33.78 USD. Book Value per Share of Syneos Health was 2021 32.98 USD. It decreases by 2.42% higher compared to the previous year.

The Syneos Health Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2015
2.10 USD
Jan 1, 2016
2.91 USD
Jan 1, 2017
29.21 USD
Jan 1, 2018
27.60 USD
Jan 1, 2019
29.28 USD
Jan 1, 2020
31.33 USD
Jan 1, 2021
32.98 USD
Jan 1, 2022
33.78 USD
The Syneos Health Book Value per Share history
YEARBook Value per ShareYoY
33.78USD+2.42%
32.98USD+5.26%
31.33USD+7.01%
29.28USD+6.07%
27.60USD-5.51%
29.21USD+902.60%
2.91USD+38.65%
2.10USD-44.56%
3.79USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Syneos Health Stock analysis

What does Syneos Health do? Syneos Health is a US-based pharmaceutical and biotech service company. They specialize in providing integrated solutions for clinical research, commercial services, and data analysis. The company was founded in 2017 through the merger of two leading service companies, INC Research and inVentiv Health. Today, Syneos Health is one of the largest providers of clinical and commercial services in the pharmaceutical and biotech industry. They support their customers in the development and marketing of medications, diagnostics, and medical devices by offering a wide range of services including planning and conducting clinical trials, data analysis and management, and product marketing. Syneos Health operates in four business areas: clinical solutions, commercial solutions, consulting services, and clinical data analysis. Their primary focus is on delivering customer-centric services that cover various aspects of the pharmaceutical and biotech industry value chain. Within their clinical and medical segment, they conduct clinical trials and provide supporting services. They have expertise in clinical research and have successfully executed numerous studies. Syneos Health also offers consulting services in the areas of data management systems and clinical trials. In the commercial segment, they assist customers with marketing, sales promotion, and channel management to ensure the successful launch and sales of products. They provide training for sales staff, market research and analysis, and continuous support from sales and marketing experts. Their consulting services encompass strategy consulting, market research, branding, and communication. They also assist with the development, implementation, and validation of clinical trials, literature research, and regulatory support. Syneos Health's clinical data analysis involves analyzing large data sets to gain insights into the healthcare industry. They utilize cutting-edge technologies such as Big Data Analytics and Machine Learning to provide customers with valuable insights that aid in decision-making. In addition to clinical trials and consulting, Syneos Health offers modern technologies for the development and marketing of medications. This includes Virtual Reality solutions, personalized patient programs for chronic disease treatment, and digital platforms for data collection, analysis, and management. Syneos Health serves globally operating pharmaceutical and biotech companies that rely on their services to develop and market innovative medications and treatment methods. Customers value Syneos Health's expertise and trust that the company will help them successfully bring their products to market. Overall, Syneos Health is a leading company in the pharmaceutical and biotech industry. Their integrated services enable customers to work faster and more effectively. By combining expertise in clinical research, commercial solutions, consulting services, and clinical data analysis, Syneos Health offers innovative and successful solutions to its customers. Syneos Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syneos Health stock

Book Value per Share of Syneos Health is 33.78 USD in 2022.

Book Value per Share of Syneos Health changed from 32.98 USD to 33.78 USD, representing a 2.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Syneos Health since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Syneos Health

All Key Metrics — Syneos Health